Big discovery in cancer treatment, scientists unveil pathbreaking device that can cure the dreaded disease

Scientists unveil pathbreaking device that can cure the dreaded disease. A study shows that tiny robots that are thinner than a human hair may be able to combat cancerous tumours.

Bladder tumour size reduction has already been achieved in a mouse trial. According to a study, minuscule robots lighter than a human hair may aid in the fight against cancerous tumours, as quoted in a report by The US Sun.

In order to deliver medications directly to cancer cells, scientists have created unique 3D-printed microrobots. They have a diameter of just 30 microns, or thousands of a millimetre, and can change from solid to liquid and back again with ease.


Also Read : Poor quality Chinese products? World’s most powerful wind turbine with typhoon-proof blades break off in China

They would leave the body in urine and are resistant to stomach acid. Bladder tumour size has already been reduced in a mouse trial. In the long run, a human test is now anticipated.

Researchers Wei Gao of Caltech University in the United States stated that they can now direct their microrobots directly to a tumour site and release the drug in a controlled and efficient way instead of putting a drug into the body and letting it diffuse everywhere.

They believe that this platform holds great promise for precision surgery and medication delivery.

Also Read : Will Justin Trudeau's government fall? Canada's Deputy PM Chrystia Freeland quits, blames the Prime Minister; here's what she said

In the long term, they hope to test this in humans. In the future, they might consider using this robot as a platform to deliver various therapeutic payloads or agents for various conditions.

FAQs

What are these microrobots, and how do they function?
These 3D-printed microrobots are 30 microns in size and can deliver drugs directly to cancer cells, releasing them precisely at tumour sites.

Have the microrobots been tested on humans?
Not yet. Successful mouse trials have demonstrated tumour reduction, and researchers hope to test them on humans in the future.